Holocene Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,527,747
Closed -$18.6M 747
2024
Q1
$18.6M Buy
+2,527,747
New +$18.6M 0.07% 217
2021
Q4
Sell
-238,576
Closed -$14.1M 893
2021
Q3
$14.1M Sell
238,576
-1,615
-0.7% -$95.7K 0.08% 209
2021
Q2
$20.8M Buy
+240,191
New +$20.8M 0.12% 172